logo

For the Inventor, By the Inventor

Wentzwiller, France

Thierry Sifferlen

This inventor holds 40 USPTO granted patents and 10 published patent applications and 16 EPO patents, primarily in Orexin Receptor Antagonists. Top assignees: Actelion Pharmaceuticals Ltd, Idorsia Pharmaceuticals Ltd, Other. Active years: 2006-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thierry Sifferlen. Retrieved from https://idiyas.com/inventor/thierry-sifferlen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 40 

% Patents Active = 45.0

 

Average Co-Inventor Count = 6.3

ph-index = 8

Forward Citations = 213(Granted Patents)


Location History:

  • Guewenheim, FR (2006 - 2012)
  • Wentzwiller, FR (2010 - 2016)
  • Allschwil, CH (2015 - 2023)

Company Filing History:

goldMedal27 out of 217 
 
Actelion Pharmaceuticals Ltd
 patents
silverMedal12 out of 81 
 
Idorsia Pharmaceuticals Ltd
 patents
bronzeMedal1 out of 834,513 
Other
 patents

Years Active: 2006-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Orexin Receptor Antagonists
Pyrimidine Derivatives
Benzimidazole Derivatives
Phenyl Derivatives
Azetidine Compounds
Pyrazole Derivatives
Proline Sulfonamide Derivatives
Lactam Derivatives
Thiazolidine Derivatives
Bicyclononene Derivatives
Quinoxalin Derivatives
Sulfonylamino-Acetic Acid Derivatives
40 patents (USPTO):Explore Patents
1. 11839613 - Pyrimidine derivatives as PGE2 receptor modulators (2023-12-12),
2. 11712438 - Phenyl derivatives as PGE2 receptor modulators (2023-08-01),
3. 11446298 - Pyrimidine derivatives (2022-09-20),
4. 11325899 - Benzofurane and benzothiophene derivatives as PGE2 receptor modulators (2022-05-10),
5. 11241431 - N-substituted indole derivatives as PGE2 receptor modulators (2022-02-08),
6. 11040966 - Benzimidazole-proline derivatives (2021-06-22),
7. 10329287 - Benzimidazole-proline derivatives (2019-06-25),
8. 10023560 - Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist (2018-07-17),
9. 9914721 - Use of benzimidazole-proline derivatives (2018-03-13),
10. 9914720 - Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists (2018-03-13),
11. 9790208 - Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist (2017-10-17),
12. 9732075 - Benzimidazole-proline derivatives (2017-08-15),
13. 9493446 - [object Object] (2016-11-15),
14. 9403813 - Azetidine amide derivatives as orexin receptor antagonists (2016-08-02),
15. 9303023 - Pyrazole and imidazole derivatives useful as orexin antagonists (2016-04-05),

Title: The Innovative Journey of Inventor Thierry Sifferlen

Introduction: Thierry Sifferlen, a talented inventor hailing from Wentzwiller, France, has made significant contributions to the world of innovations with his creative mind and dedication to progress.

Latest Patents: Thierry Sifferlen holds several patents in various fields, showcasing his versatility and ingenuity in inventing new solutions to complex problems. His latest patents focus on sustainable energy solutions and advanced materials.

Career Highlights: Throughout his illustrious career, Thierry Sifferlen has been recognized for his groundbreaking inventions that have had a positive impact on industries such as renewable energy, healthcare, and transportation. His ability to think outside the box and push the boundaries of traditional thinking has set him apart as a visionary inventor.

Collaborations: Thierry Sifferlen has collaborated with leading research institutions, universities, and innovative companies to bring his inventions to life. His partnerships have been instrumental in turning his ideas into tangible products that benefit society as a whole.

Conclusion: In conclusion, Thierry Sifferlen's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His dedication to creating a better future through his inventions serves as an inspiration to aspiring innovators around the globe.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…